RSV Injection for Infants Approved

RSV Injection for Infants Approved

On July 17, 2023, the Food and Drug Administration approved an injectable drug designed to protect children up to 2 years of age from respiratory syncytial virus (RSV). The Centers for Disease Control and Prevention’s (CDC) Advisory Committee for Immunization Practices is set to meet to determine who should be …